Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
Main Authors: | Takashi Uehara, Hiroshi Yoshida, Tomoyasu Kato |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920301582 |
Similar Items
-
Second fertility preservation surgery for early relapse of seromucinous borderline ovarian tumors
by: Motoko Kanno, et al.
Published: (2021-08-01) -
Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
by: Toshiyuki Okumura, et al.
Published: (2018-09-01) -
Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
by: Michiko Nagamine, et al.
Published: (2020-01-01) -
Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour
by: Kurata, Yasuhisa
Published: (2018) -
Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature
by: Romana Idrees, et al.
Published: (2021-03-01)